UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (9149) 9149
Dissertation (58) 58
Book Chapter (22) 22
Magazine Article (20) 20
Publication (12) 12
Conference Proceeding (9) 9
Newspaper Article (6) 6
Paper (5) 5
Reference (4) 4
Web Resource (2) 2
Book Review (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (6209) 6209
life sciences & biomedicine (5872) 5872
humans (5210) 5210
atorvastatin (5113) 5113
atorvastatin calcium (4452) 4452
male (4090) 4090
female (3202) 3202
middle aged (2704) 2704
pyrroles - therapeutic use (2631) 2631
heptanoic acids - therapeutic use (2628) 2628
statins (2140) 2140
aged (1960) 1960
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (1903) 1903
cardiovascular system & cardiology (1797) 1797
animals (1768) 1768
pyrroles - pharmacology (1690) 1690
heptanoic acids - pharmacology (1687) 1687
pharmacology & pharmacy (1566) 1566
cardiac & cardiovascular systems (1466) 1466
adult (1410) 1410
pyrroles - administration & dosage (1329) 1329
heptanoic acids - administration & dosage (1328) 1328
treatment outcome (1275) 1275
cholesterol (1202) 1202
hydroxymethylglutaryl-coa reductase inhibitors - pharmacology (1194) 1194
anticholesteremic agents - therapeutic use (1173) 1173
lipids (1046) 1046
cholesterol, ldl - blood (991) 991
abridged index medicus (966) 966
hydroxymethylglutaryl-coa reductase inhibitors - administration & dosage (952) 952
rats (815) 815
risk factors (814) 814
antilipemic agents (812) 812
hypercholesterolemia - drug therapy (772) 772
dose-response relationship, drug (761) 761
atherosclerosis (734) 734
peripheral vascular disease (679) 679
cardiovascular disease (640) 640
drug therapy (639) 639
pyrroles - adverse effects (638) 638
heptanoic acids - adverse effects (637) 637
analysis (629) 629
simvastatin (625) 625
double-blind method (609) 609
cardiovascular diseases (595) 595
drug therapy, combination (592) 592
general & internal medicine (589) 589
cholesterol - blood (575) 575
time factors (571) 571
hydroxymethylglutaryl-coa reductase inhibitors - adverse effects (565) 565
medicine, general & internal (561) 561
anticholesteremic agents - administration & dosage (552) 552
simvastatin - therapeutic use (541) 541
statin (517) 517
research (513) 513
inflammation (511) 511
anticholesteremic agents - pharmacology (506) 506
prospective studies (504) 504
mice (486) 486
hypercholesterolemia (484) 484
care and treatment (480) 480
triglycerides - blood (469) 469
lipids - blood (463) 463
cardiovascular (461) 461
biochemistry & molecular biology (451) 451
cholesterol, hdl - blood (415) 415
diabetes (412) 412
hyperlipidemias - drug therapy (395) 395
nutritional and metabolic diseases (393) 393
follow-up studies (392) 392
medicine, research & experimental (385) 385
research & experimental medicine (385) 385
cardiology (381) 381
low density lipoproteins (379) 379
coronary heart disease (378) 378
aged, 80 and over (370) 370
medicine (369) 369
cardiovascular agents (368) 368
disease models, animal (364) 364
biomarkers - blood (349) 349
hypercholesterolemia - blood (345) 345
rosuvastatin calcium (343) 343
drug interactions (342) 342
physical sciences (341) 341
chemistry (340) 340
clinical trials (339) 339
medicine & public health (326) 326
studies (324) 324
lipoproteins (323) 323
health aspects (322) 322
rosuvastatin (321) 321
rats, wistar (318) 318
cells, cultured (314) 314
pravastatin - therapeutic use (313) 313
neurosciences & neurology (312) 312
cardiovascular diseases - prevention & control (311) 311
anticholesteremic agents - adverse effects (309) 309
drugs (309) 309
patients (307) 307
rats, sprague-dawley (306) 306
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8775) 8775
Chinese (140) 140
Russian (125) 125
Spanish (115) 115
German (100) 100
Japanese (89) 89
Portuguese (68) 68
French (62) 62
Korean (26) 26
Persian (25) 25
Polish (21) 21
Hungarian (16) 16
Turkish (15) 15
Italian (14) 14
Swedish (9) 9
Dutch (7) 7
Ukrainian (7) 7
Norwegian (6) 6
Czech (5) 5
Croatian (4) 4
Danish (3) 3
Lithuanian (2) 2
Slovenian (2) 2
Belarusian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the American College of Cardiology, ISSN 0735-1097, 10/2018, Volume 72, Issue 16, pp. C174 - C175
Journal Article
International heart journal, ISSN 1349-2365, 2019
The initiation and progression of atherosclerotic cardiovascular disease (ASCVD) has always been associated with a series of risk factors. Evidences of statin... 
Atorvastatin
Journal Article
The Lancet (British edition), ISSN 0140-6736, 06/2017, Volume 389, Issue 10088, pp. 2473 - 2481
Summary Background In blinded randomised controlled trials, statin therapy has been associated with few adverse events (AEs). By contrast, in observational... 
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hematologic Diseases - chemically induced | Hypolipidemic Agents - adverse effects | Atorvastatin - adverse effects | Double-Blind Method | Nocebo Effect | Humans | Middle Aged | Risk Factors | Male | Treatment Outcome | Atorvastatin - administration & dosage | Sleep Wake Disorders | Early Termination of Clinical Trials | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Lymphatic Diseases - chemically induced | Hypolipidemic Agents - administration & dosage | Hypertension - complications | Adult | Female | Hypercholesterolemia - prevention & control | Aged | Muscular Diseases - chemically induced | Clinical trials | Medicine, Experimental | Complications and side effects | Medical research | Epidemiology | Statins | Analysis | Cardiac patients | Sexual disorders | Risk factors | Myocardial infarction | Heart | Therapy | Laboratories | Funding | Physicians | Disorders | Impairment | Cognitive ability | Lipids | Cardiovascular disease | Angina | Evidence-based medicine | Matching | Connective tissues | Disturbance | Heart diseases | Public health | Hypertension | Medical personnel | Lymphatic system | Fasting | Effectiveness | Kidneys | Health risks | Erectile dysfunction | Risk analysis | Patients | Low density lipoprotein | Cholesterol | Doctors | Side effects | Sleep | Atorvastatin | Infarction | Health risk assessment | Cardiovascular diseases | Kidney transplantation | Index Medicus | Abridged Index Medicus | Clinical Medicine | management | clinical-trials | intolerance | risk | cardiovascular-disease | Klinisk medicin | prevention | participants
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 03/2016, Volume 315, Issue 9, pp. 877 - 888
Journal Article
Journal Article
Journal Article
The New England journal of medicine, ISSN 1533-4406, 05/2014, Volume 370, Issue 19, pp. 1809 - 1819
Journal Article
The New England journal of medicine, ISSN 0028-4793, 11/2012, Volume 367, Issue 20, pp. 1891 - 1900
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 09/2013, Volume 62, Issue 10, pp. 909 - 917
Objectives The study sought to test whether high-dose statin treatment would result in greater reductions in plaque inflammation than low-dose statins, using... 
atherosclerosis | FDG | plaque | inflammation | atorvastatin | statins | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular